{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:10Z","timestamp":1788326530060,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60692-7","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T11:07:01Z","timestamp":1783422421000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["High-intensity interval training enhanced cardioprotective effects of neuregulin-1 against doxorubicin-induced cardiotoxicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Najmeh","family":"Rezaeinezhad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Jamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosar","family":"Fatholahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza Ghardashi","family":"Afousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"3","key":"60692_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"Cancer J. Clin."},{"issue":"3","key":"60692_CR2","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1002\/ctm2.124","volume":"10","author":"C Hu","year":"2020","unstructured":"Hu, C. et al. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin. Translational Med. 10 (3), e124 (2020).","journal-title":"Clin. Translational Med."},{"issue":"9","key":"60692_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","volume":"64","author":"P Vejpongsa","year":"2014","unstructured":"Vejpongsa, P. & Yeh, E. T. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities. J. Am. Coll. Cardiol. 64 (9), 938\u2013945 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"60692_CR4","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1042\/CS20200230","volume":"134","author":"A Geissler","year":"2020","unstructured":"Geissler, A., Ryzhov, S. & Sawyer, D. B. Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease. Clin. Sci. 134 (19), 2623\u20132643 (2020).","journal-title":"Clin. Sci."},{"key":"60692_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2016.02.055","volume":"149","author":"MX Cai","year":"2016","unstructured":"Cai, M. X. et al. Exercise training activates neuregulin 1\/ErbB signaling and promotes cardiac repair in a rat myocardial infarction model. Life Sci. 149, 1\u20139 (2016).","journal-title":"Life Sci."},{"issue":"6","key":"60692_CR6","doi-asserted-by":"publisher","first-page":"e66720","DOI":"10.1371\/journal.pone.0066720","volume":"8","author":"AN Chang","year":"2013","unstructured":"Chang, A. N. et al. The effects of neuregulin on cardiac Myosin light chain kinase gene-ablated hearts. PLoS One. 8 (6), e66720 (2013).","journal-title":"PLoS One"},{"issue":"1","key":"60692_CR7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11897-010-0003-y","volume":"7","author":"Z Jiang","year":"2010","unstructured":"Jiang, Z. & Zhou, M. Neuregulin signaling and heart failure. Curr. Heart Fail. Rep. 7 (1), 42\u201347 (2010).","journal-title":"Curr. Heart Fail. Rep."},{"key":"60692_CR8","doi-asserted-by":"publisher","first-page":"113278","DOI":"10.1016\/j.intimp.2024.113278","volume":"143","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. Neuregulin-1 reduces Doxorubicin-induced cardiotoxicity by upregulating YAP to inhibit senescence. Int. Immunopharmacol. 143, 113278 (2024).","journal-title":"Int. Immunopharmacol."},{"issue":"13","key":"60692_CR9","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1161\/01.CIR.0000013839.41224.1C","volume":"105","author":"DB Sawyer","year":"2002","unstructured":"Sawyer, D. B. et al. Modulation of anthracycline-induced myofibrillar disarray in rat ventricular myocytes by neuregulin-1\u03b2 and anti-erbB2: potential mechanism for trastuzumab-induced cardiotoxicity. Circulation 105 (13), 1551\u20131554 (2002).","journal-title":"Circulation"},{"issue":"6","key":"60692_CR10","doi-asserted-by":"publisher","first-page":"pH1974","DOI":"10.1152\/ajpheart.01010.2008","volume":"297","author":"Y Bian","year":"2009","unstructured":"Bian, Y. et al. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins. Am. J. Physiol. Heart Circ. Physiol. 297 (6), pH1974\u2013H1983 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"60692_CR11","doi-asserted-by":"crossref","unstructured":"Hojan, K. et al. The Preventive role of Regular Physical Training in Ventricular Remodeling, Serum Cardiac Markers, and Exercise Performance Changes in Breast Cancer in Women Undergoing Trastuzumab Therapy-An REH-HER Study. J. Clin. Med., 9(5). (2020).","DOI":"10.3390\/jcm9051379"},{"issue":"3","key":"60692_CR12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10549-017-4554-4","volume":"167","author":"AA Kirkham","year":"2018","unstructured":"Kirkham, A. A. et al. The effect of an aerobic exercise bout 24\u00a0h prior to each doxorubicin treatment for breast cancer on markers of cardiotoxicity and treatment symptoms: a RCT. Breast Cancer Res. Treat. 167 (3), 719\u2013729 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"60692_CR13","doi-asserted-by":"publisher","first-page":"177883","DOI":"10.1016\/j.ejphar.2025.177883","volume":"1003","author":"M Li","year":"2025","unstructured":"Li, M. et al. Optimizing dose selection for doxorubicin-induced cardiotoxicity in mice: A comprehensive analysis of single and multiple-dose regimens. Eur. J. Pharmacol. 1003, 177883 (2025).","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"60692_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.17221\/4971-VETMED","volume":"57","author":"P Scheer","year":"2012","unstructured":"Scheer, P. et al. Basic values of M-mode echocardiographic parameters of the left ventricle in outbreed Wistar rats. Vet. Med. 57 (1), 42\u201352 (2012).","journal-title":"Vet. Med."},{"issue":"2","key":"60692_CR15","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12079-018-0481-3","volume":"13","author":"A Ghardashi Afousi","year":"2019","unstructured":"Ghardashi Afousi, A. et al. Targeting necroptotic cell death pathway by high-intensity interval training (HIIT) decreases development of post-ischemic adverse remodelling after myocardial ischemia\/reperfusion injury. J. cell. communication Signal. 13 (2), 255\u2013267 (2019).","journal-title":"J. cell. communication Signal."},{"issue":"6","key":"60692_CR16","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1097\/HJR.0b013e3281eacef1","volume":"14","author":"MA H\u00f8ydal","year":"2007","unstructured":"H\u00f8ydal, M. A. et al. Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. Eur. J. Prev. Cardiol. 14 (6), 753\u2013760 (2007).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"11","key":"60692_CR17","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","volume":"18","author":"S Zhang","year":"2012","unstructured":"Zhang, S. et al. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat. Med. 18 (11), 1639\u20131642 (2012).","journal-title":"Nat. Med."},{"issue":"8","key":"60692_CR18","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.107.690487","volume":"116","author":"K Lemmens","year":"2007","unstructured":"Lemmens, K., Doggen, K. & De Keulenaer, G. W. Role of neuregulin-1\/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation 116 (8), 954\u2013960 (2007).","journal-title":"Circulation"},{"issue":"7","key":"60692_CR19","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2006.05.057","volume":"48","author":"X Liu","year":"2006","unstructured":"Liu, X. et al. Neuregulin-1\/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J. Am. Coll. Cardiol. 48 (7), 1438\u20131447 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"60692_CR20","first-page":"1","volume":"11","author":"A Ghanbari-Niaki","year":"2019","unstructured":"Ghanbari-Niaki, A., Nezhad, N. R. & Alizadeh, R. The effect of different Intensities of circuit resistance training on plasma neuregulin and leptin concentrations in young men. J. Sport Exerc. Physiol. 11 (2), 1\u201312 (2019).","journal-title":"J. Sport Exerc. Physiol."},{"key":"60692_CR21","doi-asserted-by":"crossref","unstructured":"Mobaseri, M., Nazarali, P. & Rezaeinezhad, N. Effect of High-Intensity Interval Training and High-Fat Diet on Nrg-1 And Pgc-1\u03b1 in Aging Rats\u2019 Heart Tissue. Int. J. Sport Stud. Health, 7(1). (2024).","DOI":"10.61838\/kman.intjssh.7.1.10"},{"issue":"7","key":"60692_CR22","first-page":"1789","volume":"60","author":"OJ Arola","year":"2000","unstructured":"Arola, O. J. et al. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 60 (7), 1789\u20131792 (2000).","journal-title":"Cancer Res."},{"issue":"3","key":"60692_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijcard.2004.11.004","volume":"100","author":"A Ascens\u00e3o","year":"2005","unstructured":"Ascens\u00e3o, A. et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int. J. Cardiol. 100 (3), 451\u2013460 (2005).","journal-title":"Int. J. Cardiol."},{"key":"60692_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jelectrocard.2019.02.009","volume":"55","author":"A Alihemmati","year":"2019","unstructured":"Alihemmati, A. et al. Effects of high-intensity interval training on the expression of microRNA-499 and pro-and anti-apoptotic genes in doxorubicin-cardiotoxicity in rats. J. Electrocardiol. 55, 9\u201315 (2019).","journal-title":"J. Electrocardiol."},{"issue":"12","key":"60692_CR25","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.yjmcc.2003.09.012","volume":"35","author":"R Fukazawa","year":"2003","unstructured":"Fukazawa, R. et al. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase\/Akt. J. Mol. Cell. Cardiol. 35 (12), 1473\u20131479 (2003).","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"60692_CR26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1161\/CIRCRESAHA.112.267286","volume":"111","author":"O Odiete","year":"2012","unstructured":"Odiete, O., Hill, M. F. & Sawyer, D. B. Neuregulin in cardiovascular development and disease. Circul. Res. 111 (10), 1376\u20131385 (2012).","journal-title":"Circul. Res."},{"issue":"2","key":"60692_CR27","doi-asserted-by":"publisher","first-page":"H213","DOI":"10.1152\/ajpheart.00646.2016","volume":"312","author":"JJ Chen","year":"2017","unstructured":"Chen, J. J. et al. Aerobic exercise in anthracycline-induced cardiotoxicity: a systematic review of current evidence and future directions. Am. J. Physiol. Heart Circ. Physiol. 312 (2), H213\u2013H222 (2017).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60692-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60692-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:50:51Z","timestamp":1788324651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60692-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60692"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60692-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"4 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee at the University of Tehran, ID: IR.UT.SPORT.REC.1404.111.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27399"}}